Efficacy of antihypertensive treatment for target organ protection in patients with masked hypertension (ANTI-MASK): a multicentre, double-blind, placebo-controlled trialResearch in context

• Published in: EClinicalMedicine Vol. 74; p. 102736
• Main Authors: Jian-Feng Huang, Dong-Yan Zhang, De-Wei An, Ming-Xuan Li, Chang-Yuan Liu, Ying-Qing Feng, Qi-Dong Zheng, Xin Chen, Jan A. Staessen, Ji-Guang Wang, Yan Li, Yi-Qing Zhang, Gui-Li Chang, Zhe Hu, Xi-Da Li, Can Liu, Jia-Yi Huang, Yu-Ling Yu, Yi-Yun Wang, Xue-Ning Zhang, Jing Yu, Rui-Xin Ma, Heng-Xia Liu, Xiao-Ping Chen, Qing-Tao Meng, Zhi-Peng Zhang, Yu Dou, Mei-Yu Zhu, Wen-Juan Wang, Li-Li Zhu, Min Zhang, Yi-Nong Jiang, Yan Lu, Wei Yu, Xiao-Ling Xu, Qiu-Yan Dai, Yu-Feng Zhu, Hui-Jie Zhang, Yu Zhang, Jin-Shun Zhang, Pei-Li Bu, Ling-Xin Liu, Jian-Jun Mu, Jing-Tao Xu, Yue-Yuan Liao, Hao Guo, Xin-Yue Liang
• Format: Journal Article
• Language: English
• Published: Elsevier 01.08.2024
• Subjects: Ambulatory blood pressure monitoring; Antihypertensive treatment; Masked hypertension; Randomised clinical trial
• ISSN: 2589-5370
• DOI: 10.1016/j.eclinm.2024.102736

Background: Masked hypertension is associated with target organ damage (TOD) and adverse health outcomes, but whether antihypertensive treatment improves TOD in patients with masked hypertension is unproven. Methods: In this multicentre, randomised, double-blind, placebo-controlled trial at 15 Chine...